Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation

被引：8
|
作者：
Kreyenberg, H. [1 ]
Eckert, C. [2 ]
Yarkin, Y. [3 ]
Reising, M. [1 ]
Willasch, A. [1 ]
Handgretinger, R. [3 ]
Kremens, B. [4 ]
von Stackelberg, A. [2 ]
Henze, G. [2 ]
Klingebiel, T. [1 ]
Bader, P. [1 ]
机构：
[1] Goethe Univ Frankfurt, Dept Paediat Oncol Haematol & Haemostaseol, Childrens Hosp, Frankfurt, Germany
[2] Humboldt Univ, Dept Paediat Oncol Haematol, Charite Hosp, Berlin, Germany
[3] Univ Tubingen, Dept Haematol Oncol, Childrens Univ Hosp, Tubingen, Germany
[4] Univ Essen Gesamthsch, Dept Pediat Haematol Oncol & Endocrinol, Essen, Germany
来源：
LEUKEMIA | 2009年 / 23卷 / 07期
关键词：
CONCERTED ACTION; RELAPSE; PROTOCOLS; CHILDREN; PRIMERS;
D O I：
10.1038/leu.2009.72
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1355 / 1358
页数：5
相关论文
共 50 条
  • [21] T-CELL RECEPTOR AND IMMUNOGLOBULIN GENE REARRANGEMENTS IN ACUTE MYELOBLASTIC-LEUKEMIA
    CHENG, GY
    MINDEN, MD
    TOYONAGA, B
    MAK, TW
    MCCULLOCH, EA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (02): : 414 - 424
  • [22] T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia reflect ‘end-stage’ recombinations: implications for minimal residual disease monitoring
    T Szczepański
    AW Langerak
    MJ Willemse
    ILM Wolvers-Tettero
    ER van Wering
    JJM van Dongen
    Leukemia, 2000, 14 : 1208 - 1214
  • [23] T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia reflect 'end-stage' recombinations:: implications for minimal residual disease monitoring
    Szczepanski, T
    Langerak, AW
    Willemse, MJ
    Wolvers-Tettero, ILM
    van Wering, ER
    van Dongen, JJM
    LEUKEMIA, 2000, 14 (07) : 1208 - 1214
  • [24] High-Throughput Sequencing of T-Cell Receptor Gene Loci for Minimal Residual Disease Monitoring in T Lymphoblastic Leukemia
    Wu, David
    Sherwood, Anna
    Winter, Stuart S.
    Dunsmore, Kimberly
    Loh, Mignon L.
    Fromm, Jonathan R.
    Greisman, Harvey A.
    Sabath, Daniel E.
    Wood, Brent L.
    Robins, Harlan
    BLOOD, 2011, 118 (21) : 1092 - 1092
  • [25] FREQUENT ONGOING T-CELL RECEPTOR REARRANGEMENTS IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR MONITORING MINIMAL RESIDUAL DISEASE
    STEENBERGEN, EJ
    VERHAGEN, OJHM
    VANLEEUWEN, EF
    VANDENBERG, H
    VONDEMBORNE, AEGK
    VANDERSCHOOT, CE
    BLOOD, 1995, 86 (02) : 692 - 702
  • [26] T-Cell Acute Lymphoblastic Leukemia, Minimal Residual Disease, and Lymphocyte Recovery
    Naithani, Rahul
    Abdelhaleem, Mohammad
    Punnett, Angela
    PEDIATRIC BLOOD & CANCER, 2016, 63 (05) : 944 - 944
  • [27] Post Stem Cell Transplantation Monitoring in Acute Myeloid Leukemia by Markers of Minimal Residual Disease and Engraftment
    Kim, A. S.
    Kressin, M. K.
    Mosse, C. A.
    Seegmiller, A.
    LABORATORY INVESTIGATION, 2012, 92 : 347A - 347A
  • [28] Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets -: Report of the BIOMED-1 CONCERTED ACTION:: Investigation of minimal residual disease in acute leukemia
    Pongers-Willemse, MJ
    Seriu, T
    Stolz, F
    d'Aniello, E
    Gameiro, P
    Pisa, P
    Gonzalez, M
    Bartram, CR
    Panzer-Grümayer, ER
    Biondi, A
    San Miguel, JF
    van Dongen, JJM
    LEUKEMIA, 1999, 13 (01) : 110 - 118
  • [29] Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia
    MJ Pongers-Willemse
    T Seriu
    F Stolz
    E d’Aniello
    P Gameiro
    P Pisa
    M Gonzalez
    CR Bartram
    ER Panzer-Grümayer
    A Biondi
    JF San Miguel
    JJM van Dongen
    Leukemia, 1999, 13 : 110 - 118
  • [30] Post Stem Cell Transplantation Monitoring in Acute Myeloid Leukemia by Markers of Minimal Residual Disease and Engraftment
    Kim, A. S.
    Kressin, M. K.
    Mosse, C. A.
    Seegmiller, A.
    MODERN PATHOLOGY, 2012, 25 : 347A - 347A
12345